Stocklytics Platform
Asset logo for symbol RAPT
RAPT Therapeutics
Penny Stock
Asset logo for symbol RAPT



Income Statement (RAPT)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
gross Profit-$314.00K$4.96M-$908.00K-$853.00K-$883.00K
NET Income-$30.52M-$30.87M-$31.37M-$25.28M-$26.98M
total Revenue$0.00$5.28M$0.00$0.00$0.00

Balance Sheet (RAPT)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt-$38.99M-$40.57M-$46.67M-$42.16M-$37.24M
stockholders Equity$130.83M$147.03M$172.80M$199.67M$220.47M
total Assets$155.81M$173.32M$199.72M$220.75M$248.32M
total Debt$6.32M$6.90M$7.46M$7.99M$8.52M
total Liabilities$24.98M$26.29M$26.92M$21.07M$27.85M

Cash Flow (RAPT)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow$9.03M$458.00K$106.00K$767.00K$116.00K
free Cash Flow-$27.18M-$27.82M-$21.95M-$29.04M-$19.36M
investing Cash Flow---$32.43M$25.30M
operating Cash Flow-$27.08M-$27.75M-$21.88M-$28.80M-$18.60M

RAPT Therapeutics (RAPT) Financials

The income statement of RAPT Therapeutics Inc (RAPT) provides a summary of the company's revenues, expenses, and net income over a specific period. It shows how much money the company has generated from its operations and how it has allocated those funds. The ebit (earnings before interest and taxes) is an important measure of a company's profitability. It represents the company's operating income before deducting interest and taxes. Ebitda (earnings before interest, taxes, depreciation, and amortization) is another measure that provides a clearer picture of a company's operating performance by excluding non-operating expenses. The gross profit is the difference between a company's total revenue and its cost of goods sold. It reflects the company's ability to generate profit from its core operations. The net income from stockholders is the amount of profit or loss distributed to the company's stockholders. The total revenue represents the total amount of money generated by the company from its operations. The balance sheet of RAPT Therapeutics Inc (RAPT) provides a snapshot of the company's financial position at a specific point in time. It lists the company's assets, liabilities, and stockholders' equity. The cash equivalents are highly liquid assets that can be easily converted into cash. They include short-term investments such as treasury bills and money market funds. Net debt is the difference between a company's total debt and its cash and cash equivalents. It represents the company's overall financial leverage. Stockholders' equity is the residual interest in the company's assets after deducting its liabilities. It represents the company's net worth. Total assets include all of the company's resources that have economic value. They include both tangible assets such as property, plant, and equipment, as well as intangible assets such as patents and trademarks. Total debt represents the company's outstanding liabilities, including long-term debt, short-term debt, and any other obligations. Total liabilities include all of the company's legal and financial obligations. They include both current liabilities such as accounts payable and long-term liabilities such as deferred taxes. Cash flow is the movement of money into or out of a company. It measures the company's ability to generate cash and manage its cash resources. Financing cash flow includes activities related to the company's financing, such as issuing or repurchasing stock and borrowing or repaying debt. Free cash flow is the amount of cash that a company has left over after paying for its operating expenses and investing in its capital assets. It represents the cash available to the company for distribution to its stockholders or for reinvestment in the business. Investing cash flow includes activities related to the company's investments, such as purchasing or selling assets and making or collecting loans. Operating cash flow represents the cash generated or used by a company's core operating activities, such as sales and production.

add RAPT Therapeutics  to watchlist

Keep an eye on RAPT Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level